Redeye provides its comprehensive Q1 2026 update for the Swedish listed investment company universe,...
Biovica announced this morning an expanded work order within its Pharma Services division from a cli...
Redeye updates on Better Collective after Q1-results which were close to our expectations while the ...
* Prioritising profitability, targeting 12% EBITA margin * Building on the 15+ years of defence expe...
* aXivite drev intäkterna under Q1 * aXiphen godkänt för idisslare i Brasilien * Vårt motiverade vä...
Redeye gives an initial comment on Eisai’s FY2028 Leqembi simulation.
* Adj. EBITA -3%/-2%/+1% in '26e/'27e/'28e; North America delivers * We estimate positive EBITA grow...
* The chemical company project seemingly back on track * The Chematur MoU converted into an agreemen...
Redeye leaves a comment following today’s announcement of the final subscription terms for Alzinova’...
Botnia Gold levererade ett starkt första kvartal trots en ovanligt kall vinter med produktionsstörni...
Redeye provides a review following GBK’s Q1 report, which showed stronger topline and EBIT than we h...
Regeringen har beviljat Bluelake Minerals bearbetningskoncession Stekenjokk K nr 1 vilket sänker ris...
Redeye updates on Embracer after Q4-results which were stronger-than-expected while 2026/27E guidanc...
Redeye resumes coverage and updates its view on Nanologica following the equity issues, the Syntagon...
Ett nordiskt mjukvarubolag under produktmigration accelererar nu från låga nivåer.
* Benefiting from becoming a larger company * Eyeing a Nordic expansion * Potential in the SOC busin...
Seafire’s transformation efforts are beginning to deliver tangible results, with improving margins, ...
* Sports margin weak in Feb'26 * Minor estimate revisions * Trading below peers at 4.
* CEO highlighted AI as a "big friend to our firm at the moment" * Anthropic customer case sounds at...
Beyond Frames redovisade för Q1’26 totala intäkter om 27,8 MSEK (49,9), där den lägre nettoomsättnin...